Open an account

Heartbeam

BEAT · NASDAQ

$0.4108−$0.0022 (−0.53%)TodayMarket closed ·
Prev close $0.413

About BEAT

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.

Employees
16
Headquarters
Santa Clara, California
Listed
Oct 14, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
heartbeam.com

BEAT key statistics

Market cap
23.15M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
22.20M
Volume
505.33K
Open price
$0.4108
High today
$0.425
Low today
$0.403
52 Week high
$4.00
52 Week low
$0.355

Heartbeam (BEAT) at a glance

As of Oct 20, 2026, Heartbeam (BEAT) shares are priced at $0.4108, giving the company a market cap of 23.15M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.403 and $0.425. The current price is 1.9% above the day's low and 3.3% below its high.

Volume so far is 505.33K shares, below the average of 22.20M shares a day.

Over the past year Heartbeam has ranged from $0.355 to $4.00, and now sits 2% of the way up that range.

Heartbeam met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported -$0.10 per share against an estimate of -$0.0918.

The average analyst price target is $3.57, 769.0% above the current price, from 5 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

80%of 5 analyst ratings say Buy
  • Buy80.0%
  • Hold20.0%
  • Sell0.0%
Price target · 4 analystsAvg $3.57
Low
$2.02
Now
$0.4108
High
$5.25

BEAT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 10.0% on average.

  1. Q3 FY24: reported -$0.19 per share against an estimate of -$0.1785
  2. Q4 FY24: reported -$0.18 per share against an estimate of -$0.1938
  3. Q1 FY25: reported -$0.18 per share against an estimate of -$0.153
  4. Q2 FY25: reported -$0.15 per share against an estimate of -$0.1632
  5. Q3 FY25: reported -$0.15 per share against an estimate of -$0.1319
  6. Q4 FY25: reported -$0.14 per share against an estimate of -$0.139
  7. Q1 FY26: reported -$0.12 per share against an estimate of -$0.1408
  8. Q2 FY26: reported -$0.10 per share against an estimate of -$0.0918

BEAT news

  • Press releaseBusiness Wire

    HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients

  • Vandana Singh

    HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System

  • Avi Kapoor

    Dow Gains 100 Points; ISM Services PMI Falls In September

  • Press releaseGlobe Newswire

    Commercial Orders, FDA Firepower and Crypto Momentum

  • Avi Kapoor

    US Stocks Mixed; Nasdaq Gains Over 50 Points

  • Press releaseBusiness Wire

    HeartBeam Receives FDA Breakthrough Device Designation for Heart Attack Assessment

  • Press releaseBusiness Wire

    HeartBeam, Inc. Letter to Shareholders

  • 12 Health Care Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as Heartbeam

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.